Ultragenyx Pharmaceutical
RARE
#4305
Rank
C$3.97 B
Marketcap
C$40.35
Share price
0.32%
Change (1 day)
12.39%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: C$3.97 Billion

As of July 2026 Ultragenyx Pharmaceutical has a market cap of C$3.97 Billion. This makes Ultragenyx Pharmaceutical the world's 4305th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026C$3.97 B-12.02%
2025C$4.51 B-21.49%
2024C$5.75 B10.47%
2023C$5.20 B18.17%
2022C$4.40 B-39.66%
2021C$7.30 B-37.44%
2020C$11.67 B261.93%
2019C$3.22 B7.1%
2018C$3.01 B21.3%
2017C$2.48 B-35.67%
2016C$3.86 B-36.19%
2015C$6.05 B272.08%
2014C$1.62 B

End of Day market cap according to different sources

On Jul 21st, 2026 the market cap of Ultragenyx Pharmaceutical was reported to be:

C$3.97 Billion
by Nasdaq info icon info icon
C$3.97 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Lexicon Pharmaceuticals
LXRX
C$1.49 B-62.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$1.15 B-70.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$6.41 B 61.41%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$16.13 B 306.01%๐Ÿ‡บ๐Ÿ‡ธ USA